We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+22.23%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$18.5B
AUM Growth
+$2.83B
Cap. Flow
+$342M
Cap. Flow %
1.85%
Top 10 Hldgs %
16.55%
Holding
2,427
New
891
Increased
366
Reduced
546
Closed
599

Top Buys

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$163M
2
CCL icon
Carnival Corporation Ltd
CCL
+$137M
3
RGEN icon
Repligen
RGEN
+$104M
4
BIIB icon
Biogen
BIIB
+$104M
5
ZTS icon
Zoetis
ZTS
+$91.9M

Sector Composition

Rank Sector Weight
1 Healthcare 28.24%
2 Consumer Discretionary 12.89%
3 Financials 10.77%
4 Technology 9.62%
5 Industrials 4.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FIVN icon
1326
FIVE9
FIVN
$2.08B
$727K ﹤0.01%
+4,168
New +$634K
WPRT
1327
Westport Fuel Systems
WPRT
$32.9M
$726K ﹤0.01%
+13,626
New +$428K
MASI
1328
DELISTED
Masimo
MASI
$724K ﹤0.01%
+2,697
New +$673K
OIH icon
1329
PUT
VanEck Oil Services ETF
OIH
$1.99B
$724K ﹤0.01%
+4,700
New +$596K
UHAL icon
1330
U-Haul Holding Co
UHAL
$14.4B
$722K ﹤0.01%
+15,920
New +$634K
SBH icon
1331
Sally Beauty Holdings
SBH
$1.47B
$720K ﹤0.01%
55,257
-150,213
-73% -$1.6M
SPG icon
1332
Simon Property Group
SPG
$76.9B
$719K ﹤0.01%
+8,431
New +$644K
RPM icon
1333
RPM International
RPM
$14.3B
$717K ﹤0.01%
7,896
-12,245
-61% -$1.08M
TM icon
1334
Toyota
TM
$220B
$717K ﹤0.01%
4,639
-5,375
-54% -$751K
LE icon
1335
Lands' End
LE
$392M
$716K ﹤0.01%
+33,192
New +$610K
AAMI
1336
Acadian Asset Management
AAMI
$2.94B
$715K ﹤0.01%
+37,106
New +$624K
CANG
1337
Cango Inc
CANG
$67.3M
$714K ﹤0.01%
+10,200
New +$668K
KRC icon
1338
Kilroy Realty
KRC
$4.47B
$714K ﹤0.01%
+12,447
New +$700K
PRAA icon
1339
PRA Group
PRAA
$693M
$710K ﹤0.01%
17,906
-84,258
-82% -$3.34M
XLRN
1340
DELISTED
Acceleron Pharma
XLRN
$706K ﹤0.01%
+5,519
New +$647K
MGP
1341
DELISTED
MGM Growth Properties LLC Class A common shares representing limited liability company interests
MGP
$705K ﹤0.01%
22,534
-20,983
-48% -$625K
PAR icon
1342
PAR Technology
PAR
$720M
$704K ﹤0.01%
+11,209
New +$550K
BAH icon
1343
Booz Allen Hamilton
BAH
$8.79B
$700K ﹤0.01%
8,027
-24,509
-75% -$2.08M
XOMA
1344
DELISTED
Xoma
XOMA
$700K ﹤0.01%
15,872
-15,466
-49% -$466K
UBSI icon
1345
United Bankshares
UBSI
$6.67B
$699K ﹤0.01%
+21,567
New +$609K
FLY
1346
DELISTED
Fly Leasing Limited
FLY
$698K ﹤0.01%
70,877
-123,724
-64% -$966K
FSV icon
1347
FirstService
FSV
$6.57B
$697K ﹤0.01%
5,100
-19,379
-79% -$2.61M
IEF icon
1348
PUT
iShares 7-10 Year Treasury Bond ETF
IEF
$47.4B
$696K ﹤0.01%
+5,800
New +$698K
DRNA
1349
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$696K ﹤0.01%
31,591
-73,818
-70% -$1.63M
ZION icon
1350
Zions Bancorporation
ZION
$10.1B
$693K ﹤0.01%
+15,947
New +$590K

Similar funds

Marshall Wace's Q4 2020 Portfolio in Review

As of Q4 2020, Marshall Wace held 2,427 positions worth $18.5B, up 18% from $15.6B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Marshall Wace's Q4 2020 filing shows 891 new, 366 increased, 546 reduced and 599 closed positions. Its largest new stake was Natera: 911,254 shares worth $90.7M. The largest sale was Alphabet (Google) Class A, an estimated $173M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Marshall Wace's largest Q4 2020 buy was Natera: 911,254 shares worth $90.7M.
  • Marshall Wace added most to Thermo Fisher Scientific in Q4 2020, an estimated $163M increase.
  • Marshall Wace's biggest Q4 2020 reduction was Alphabet (Google) Class A, cutting an estimated $173M.
  • Marshall Wace fully exited FedEx in Q4 2020, selling an estimated $69.6M.
  • Marshall Wace's ten largest holdings make up 17% of its $18.5B portfolio in Q4 2020.
  • Marshall Wace opened 891 new positions and closed 599 in Q4 2020.
  • Marshall Wace's portfolio value rose 18% quarter-over-quarter to $18.5B.

Based on Marshall Wace's 13F filing for Q4 2020, filed 16 Feb 2021.